Cargando…
High-Throughput Screening for the Identification of New Therapeutic Options for Metastatic Pheochromocytoma and Paraganglioma
Drug repurposing or repositioning is an important part of drug discovery that has been growing in the last few years for the development of therapeutic options in oncology. We applied this paradigm in a screening of a library of about 3,800 compounds (including FDA-approved drugs and pharmacological...
Autores principales: | Giubellino, Alessio, Shankavaram, Uma, Bullova, Petra, Schovanek, Jan, Zhang, Yaqin, Shen, Min, Patel, Nikita, Elkahloun, Abdel, Lee, Min-Jung, Trepel, Jane, Ferrer, Marc, Pacak, Karel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974653/ https://www.ncbi.nlm.nih.gov/pubmed/24699253 http://dx.doi.org/10.1371/journal.pone.0090458 |
Ejemplares similares
-
Targeting Heat Shock Protein 90 for the Treatment of Malignant Pheochromocytoma
por: Giubellino, Alessio, et al.
Publicado: (2013) -
Anti-Cancer Potential of MAPK Pathway Inhibition in Paragangliomas–Effect of Different Statins on Mouse Pheochromocytoma Cells
por: Fliedner, Stephanie M. J., et al.
Publicado: (2014) -
Pheochromocytoma (PHEO) and Paraganglioma (PGL)
por: Pacak, Karel, et al.
Publicado: (2019) -
New insights on the pathogenesis of paraganglioma and pheochromocytoma
por: Kantorovich, Vitaly, et al.
Publicado: (2018) -
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
por: Ilanchezhian, Maran, et al.
Publicado: (2020)